Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) Operating Expenses (2016 - 2025)

Firefly Neuroscience has reported Operating Expenses over the past 15 years, most recently at $6000.0 for Q4 2025.

  • Quarterly results put Operating Expenses at $6000.0 for Q4 2025, down 99.83% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (down 53.76% YoY), and the annual figure for FY2025 was $159000.0, down 98.44%.
  • Operating Expenses for Q4 2025 was $6000.0 at Firefly Neuroscience, down from $10000.0 in the prior quarter.
  • Over the last five years, Operating Expenses for AIFF hit a ceiling of $4.3 million in Q4 2021 and a floor of $6000.0 in Q4 2025.
  • Median Operating Expenses over the past 5 years was $1.3 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Operating Expenses: soared 472.63% in 2021 and later tumbled 99.83% in 2025.
  • Firefly Neuroscience's Operating Expenses stood at $4.3 million in 2021, then tumbled by 64.12% to $1.5 million in 2022, then increased by 3.23% to $1.6 million in 2023, then surged by 119.99% to $3.5 million in 2024, then tumbled by 99.83% to $6000.0 in 2025.
  • The last three reported values for Operating Expenses were $6000.0 (Q4 2025), $10000.0 (Q3 2025), and $15000.0 (Q2 2025) per Business Quant data.